Plus   Neg

Ligand Pharmaceuticals Inc Q3 adjusted earnings Beat Estimates

Ligand Pharmaceuticals Inc (LGND) released earnings for its third quarter that climbed from last year.

The company's profit totaled $67.36 million, or $2.80 per share. This compares with $8.43 million, or $0.36 per share, in last year's third quarter.

Excluding items, Ligand Pharmaceuticals Inc reported adjusted earnings of $31.66 million or $1.32 per share for the period.

Analysts had expected the company to earn $1.03 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 36.8% to $45.66 million from $33.38 million last year.

Ligand Pharmaceuticals Inc earnings at a glance:

-Earnings (Q3): $31.66 Mln. vs. $15.30 Mln. last year.
-EPS (Q3): $1.32 vs. $0.69 last year.
-Analysts Estimate: $1.03
-Revenue (Q3): $45.66 Mln vs. $33.38 Mln last year.

Full year revenue guidance: $240 Mln

For comments and feedback contact: editorial@rttnews.com

Follow RTT